Cancer Test

“Your facilitation of the group and chat was spot-on, and we got some really valuable feedback (which has since been echoed in another session too). Thank you again!”

Project Manager, PinPoint Cancer Test

The PinPoint Test is a new blood test which uses artificial intelligence to produce a calibrated probability that a patient has cancer. This test will be offered to patients who have cancer symptoms and are being referred urgently for cancer investigations. Once the test is implemented fully, it will be used to support hospital clinical teams to triage their patients. PinPoint asked us to recruit 15 Surrey residents to join a focus group and for us to facilitate the session so they could introduce the PinPoint test and get feedback from a patient perspective on acceptability of the use of the test, terminology used and to understand questions people may have.

NW Surrey Hospital at Home Report

Egestas scelerisque fringilla sit tempus ut orci. Pretium et sed urna vitae pharetra convallis nunc tincidunt vel. Mattis egestas sed nunc.

PCN-Improved-Access

Egestas scelerisque fringilla sit tempus ut orci. Pretium et sed urna vitae pharetra convallis nunc tincidunt vel. Mattis egestas sed nunc.

PCN-Improved-Access Final Report

Egestas scelerisque fringilla sit tempus ut orci. Pretium et sed urna vitae pharetra convallis nunc tincidunt vel. Mattis egestas sed nunc.

Summary: Patient feedback on new PinPoint Cancer Test

A summary about the focus group work to gather feedback from a patient perspective on acceptability of the use of the test, terminology used and to understand questions people may have.
Summary

Cancer Test

Project Manager, PinPoint Cancer Test

Summary: Patient feedback on new PinPoint Cancer Test